|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Single atom catalytic oxidation mechanism of formaldehyde on Al doped graphene at room temperature显示文摘Formaldehyde(HCHO) is one kind of common indoor toxic pollutant,the catalytic oxidation degradation of formaldehyde at room temperature is desired.In this work,a new single atomic catalyst(SAC),Al doped graphene,for the catalytic oxidation of HCHO molecules was proposed through density function theory(DFT) calculations.It is found that Al atoms can be adsorbed on graphene stably without aggre s sion.Then HCHO can be effectively oxidized into CO2 and H2 O in the presence of O2 molecules on Al doped graphene with a low energy barrier of 0.82 eV and releasing energy of 2.29 eV with the pathway of HCHO→HCOOH→CO→CO2.The oxidation reaction can happen promptly with reaction time τ=56.9 s at the speed control step at room temperature.Therefore,this work proposed a high-performance catalyst Al-doped graphene without any noble metal for HCHO oxidation at ambient temperature,and corresponding oxidation pathway and mechanism are also deeply understood. | Guanlan Liu Jtmhui Zhou Weina Zhao Zhimin Ao Taicheng An | 2020 | Chinese Chemical Letters2020，31，7： | 3 |
| 2 | Synthesis and characterization of novel magnetic Fe3O4/polyurethane foam composite applied to the carrier of immobilized microorganisms for wastewater treatment显示文摘 | Lincheng Zhou Guiying Li Taicheng An Yanfeng Li | 2010 | Research on Chemical Intermediates2010，，3： | 1 |
| 3 | Synthesis and characterization of novel magnetic Fe30 polyurethane foam composite to the carrier of immobilized microorganisms for wastewater treatment显示文摘 | Zhou Lilin An Taicheng Li Yanfeng | 2010 | Res Chem Intermed2010，36，： | 1 |
| 4 | A third dose of inactivated SARS-CoV-2 vaccine induces robust antibody responses in people with inadequate response to two-dose vaccination显示文摘Mass application of SARS-CoV-2 vaccines is a major approach to reduce SARS-CoV-2 transmission and COVID19 symptoms worldwide.The inactivated SARS-CoV-2 vaccine is one of the most widely administered vaccine types in many countries,with over 2 billion doses administered as of 31 August 2021.However,clinical trials estimate 65%–85%protection from detectable symptoms for inactivated SARS-CoV-2 vaccines[1–4],with 15%–35%of people remaining insufficiently protected after two-dose immunization.Immune protectionforthese‘non-responders’is critical for population immunity as established by mass vaccination.A third dose of inactivated(CoronaVac)vaccine has been shown to boost antibody response by between 3–5 folds in the general population[5].Whether a third dose can induce an adequate antibody response in‘non-responders’remains unclear.Here we report a trial of a third dose in a cohort of 105 vaccinated participants(Supplementary Fig.S1)with suboptimal antibody responses(non-responders)aftertwo doses(43.8%were men;average age 43±11 years[±SD];average BMI 23.5±3.4[±SD],Supplementary Table S1). | Taicheng Zhou Tianpei Shi Ao Li Lingzhi Zhu Xinshuai Zhao Naiyin Mao Wanting Qin Hanfang Bi Mei Yang Muxian Dai Fengwei Liu Rong Wang Wei Su Liang Zhang Wenbo Xu Jia Wei Zijie Zhang | 2022 | National Science Review2022，9，7： | 0 |
| 5 | The expression status of ZIC2 is an independent prognostic marker of hepatocellular carcinoma显示文摘Background:Zinc finger protein of cerebellum 2(ZIC2)is a transcriptional activator or repressor that is important for the organogenesis of the central nervous system.Previous studies have reported that ZIC2 is widely upregulated in a variety of tumors.Methods:Oncomine database was used to evaluate the expression levels of ZIC2 in hepatocellular car-cinoma(HCC)and normal liver tissues.Quantitative real-time polymerase chain reaction and immu-nohistochemistry were conducted to validate the results from the database.Cox regression analysis and survival curves were performed to assess the survival effect of ZIC2 in HCC.Results:Increased expression of ZIC2 was detected in HCC tissues compared with normal liver tissues.In addition,patients with high ZIC2 levels had a poor prognosis.Multivariate analysis showed that clinical stage(T or M classification)and ZIC2 levels were independent prognostic factors for overall survival.Moreover,a subgroup analysis revealed that patients with moderate or poor grade tumors,T1e2 tumors,N0 tumors,early American Joint Committee on Cancer(AJCC)stage,and old age were more likely to present with overexpression of ZIC2.To conclude,ZIC2 is upregulated in HCC and associated with the histology and survival of HCC patients. | Qinglei Kong Wenchao Li Pan Hu Hua Zeng Yuhang Pan Taicheng Zhou Kunpeng Hu | 2020 | Liver Research2020，4，1： | 0 |
| 6 | Safety,immunogenicity,and preliminary efficacy of a randomized clinical trial ofomicron XBB.1.5-containing bivalent mRNA vaccine显示文摘Periodically updating coronavirus disease 19(COVID-19)vaccines that offer broad-spectrum protection is needed giventhe strong immune evasion by the circulating omicron sublineages.The effectiveness of prototype and BA.4/5-containing bivalent mRNA vaccines is reduced when XBB subvariants predominate.We initiated an observer-blinded,threearms study in 376 patients in Chinese individuals aged from 18 to 55 years old who had previously received three dosesCOVID-19 vaccine.Immunogenicity in terms of neutralizing antibodies elicited by a 30-mg dose of XBB.1.5-containingbivalent vaccine(RQ3027),a 30-mg dose of BA.2/BA.5-Alpha/Beta bivalent vaccine(RQ3025)and their precedent 30-mg Alpha/Beta(combined mutations)monovalent mRNA vaccine(RQ3013)and safety are primary and secondary endpoints,respectively.We recorded prescribed COVID-19 cases to explore the preliminary efficacy of three vaccines.RQ3027 and RQ3025 boosters elicited superior neutralizing antibodies(NAbs)against XBB.1.5,XBB.1.16,XBB.1.9.1,and JN.1 compared to RQ3013 at day 14 in participants without SARS-CoV-2 infection.All study vaccines were welltolerated without serious adverse reactions identified.The incidence rates per 1000 person-years of COVID-19 casesduring the 2nd-19th week after randomization were lowest in RQ3027.Overall,our data show that XBB.1.5-containingbivalent booster generated superior immunogenicity and better protection against newer severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)variants compared to BA.2/BA.5-containing bivalent and Alpha/Beta monovalentwith no new safety concerns. | Xuanjing Yu Wei Yang Wei Li Na Wan Guanghong Yan Zumi Zhou Xiao Zhu Wei Su Yani Li Chenyu Xing Sifan Duan Houze Yu Xinshuai Zhao Chunmei Li Taicheng Zhou Dingyun You Jia Wei Zijie Zhang | 2024 | hLife2024，2，3： | 0 |
| 7 | Dynactin 2 acts as an oncogene in hepatocellular carcinoma through promoting cell cycle progression显示文摘Background:Dynactin(DCTN)can activate cytoplasmic dynein and drive intracellular organelle transport containing six family members(DCTN1 to DCTN6).The DCTN family has been studied as cancer-related genes or biomarkers in various cancers.Nevertheless,in hepatocellular carcinoma(HCC),the functions and prognostic roles of the DCTN family have been unexplored.Methods:We evaluated the diagnostic and survival effects of DCTN subunits in HCC through bioinformatics analysis and validated the results of bioinformatics by our data to address this problem.Results:The results of bioinformatics analysis found that DCTN2 was a significant prognostic factor in HCC,and high-level DCTN2 can predict poor patient survival in HCC.Cox regression analysis also suggested that DCTN2(hazard ratio=1.748,95%confidence interval 1.190-2.568,P=0.004)is an independent prognostic factor for patient survival.Western blot and quantitative reverse transcriptionpolymerase chain reaction assays confirmed that the protein and mRNA expression levels of DCTN2 were upregulated in HCC cell lines.The proliferation,invasion,and migration were decreased and cell apoptosis was enhanced after DCTN2 was knocked down in Huh7 and Hep3B cells.DCTN2 promoted the cell cycle progression through regulating the expression of cell cycle regulatory proteins cyclindependent kinase 4,Cyclin D1,and p21.Conclusions:We propose that DCTN2 can serve as a prognostic marker for HCC.DCTN2 acts as an oncogene and promotes the cell cycle progression through the G1/S phase-related signaling pathway. | Wenchao Li Jiehuan Chen Zhiyong Xiong Hui Zhou Shaozhuo Huang Jie Ren Bo Liu Taicheng Zhou Kunpeng Hu | 2022 | Liver Research2022，6，3： | 0 |
| 8 | Novel Ag-bridged dual Z-scheme g-C_(3)N_(4)/BiOI/AgI plasmonic heterojunction: Exceptional photocatalytic activity towards tetracycline and the mechanism insight显示文摘Rational design and synthesis of highly efficient and robust photocatalysts with positive exciton splitting and interfacial charge transfer for environmental applications is critical.Herein,aiming at overcoming the common shortcomings of traditional photocatalysts such as weak photoresponsivity,rapid combination of photo-generated carriers and unstable structure,a novel Ag-bridged dual Z-scheme g-C_(3)N_(4)/BiOI/AgI plasmonic heterojunction was successfully synthesized using a facile method.Results showed that Ag-AgI nanoparticles and three-dimensional(3D)BiOI microspheres were decorated highly uniformly on the 3D porous g-C_(3)N_(4) nanosheet,resulting in a higher specific surface area and abundant active sites.The optimized 3D porous dual Z-scheme g-C_(3)N_(4)/BiOI/Ag-AgI manifested exceptional photocatalytic degradation efficiency of tetracycline(TC)in water with approximately 91.8%degradation efficiency within 165 min,outperforming majority of the reported g-C_(3)N_(4)-based photocatalysts.Moreover,g-C_(3)N_(4)/BiOI/Ag-AgI exhibited good stability in terms of activity and structure.In-depth radical scavenging and electron paramagnetic resonance(EPR)analyses confirmed the relative contributions of various scavengers.Mechanism analysis indicated that the improved photocatalytic performance and stability were ascribed to the highly ordered 3D porous framework,fast electron transfer of dual Z-scheme heterojunction,desirable photocatalytic performance of BiOI/AgI and synergistic effect of Ag plasmas.Therefore,the 3D porous Z-scheme g-C_(3)N_(4)/BiOI/Ag-AgI heterojunction had a good prospect for applications in water remediation.The current work provides new insight and useful guidance for designing novel structural photocatalysts for environment-related applications. | Wenxia Wang Zhen Li Kailin Wu Guodong Dai Qingping Chen Lihua Zhou Junxia Zheng Liang Ma Guiying Li Wanjun Wang Taicheng An | 2023 | Journal of Environmental Sciences2023，，9： | 0 |
| 9 | A Prognostic Nomogram with High Accuracy Based on 2D-SWE in Patients with Acute-on-chronic Liver Failure显示文摘Background and Aims:Acute-on-chronic liver failure(ACLF)is associated with very high mortality.Accurate prediction of prognosis is critical in navigating optimal treatment decisions to improve patient survival.This study was aimed to develop a new nomogram integrating two-dimensional shear wave elastography(2D-SWE)values with other independent prognostic factors to improve the precision of predicting ACLF patient outcomes.Methods:A total of 449 consecutive patients with ACLF were recruited and randomly allocated to a training cohort(n=315)or a test cohort(n=134).2D-SWE values,conventional ultrasound features,laboratory tests,and other clinical characteristics were included in univariate and multivariate analysis.Factors with prognostic value were then used to construct a novel prognostic nomogram.Receiver operating curves(ROCs)were generated to evaluate and compare the performance of the novel and published models including the Model for EndStage Liver Disease(MELD),MELD combined with sodium(MELD-Na),and Jin’s model.The model was validated in a prospective cohort(n=102).Results:A ACLF prognostic nomogram was developed with independent prognostic factors,including 2D-SWE,age,total bilirubin(TB),neutrophils(Neu),and the international normalized ratio(INR).The area under the ROC curve(AUC)was 0.849 for the new model in the training cohort and 0.861 in the prospective validation cohort,which were significantly greater than those for MELD(0.758),MELD-Na(0.750),and Jin’s model(0.777,all p<0.05).Calibration curve analysis revealed good agreement between the predicted and observed probabilities.The new nomogram had superior overall net benefit and clinical utility.Conclusions:We established and validated a 2D-SWE-based noninvasive nomogram to predict the prognosis of ACLF patients that was more accurate than other prognostic models. | Lili Wu Jieyang Jin Taicheng Zhou Yuankai Wu Xinhua Li Xiangyong Li Jie Zeng Jinfen Wang Jie Ren Yutian Chong Rongqin Zheng | 2022 | Journal of Clinical and Translational Hepatology2022，10，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员